1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RAYZEBIO INC.

RayzeBio Inc.

XNAS: RYZB

Watchlist

Portfolio

Share


Insider Trading disclosures for RayzeBio Inc.

The latest disclosure was made by Kush Arvind in RayzeBio Inc. where a trade of 78,433 Common Stock done at an average price of $62.5 was reported to US exchanges on Feb. 26, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kush Arvind CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 78,433 0 - 62.5 4,902,063 Common Stock
Mary Tagliaferri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 73,731 0 - - Employee Stock Option (right to buy)
Moran Susan CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 194,514 0 - - Employee Stock Option (right to buy)
Mary Tagliaferri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 40,848 0 - - Employee Stock Option (right to buy)
Angie You Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 40,848 0 - - Employee Stock Option (right to buy)
Song Kenneth Director, PRESIDENT AND CHIEF EXECUTIVE Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 114,763 0 - - Employee Stock Option (right to buy)
Susan Moran CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 77,805 0 - - Employee Stock Option (right to buy)
Katabi Maha Director Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 1,209,764 0 - 62.5 75,610,250 Common Stock
Moran Susan CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 164,000 0 - - Employee Stock Option (right to buy)
Larson Yi Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 59,399 0 - - Employee Stock Option (right to buy)
Moran Susan CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 323,455 0 - 62.5 20,215,938 Common Stock
Larson Yi Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 14,332 0 - - Employee Stock Option (right to buy)
Yi Larson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 40,848 0 - - Employee Stock Option (right to buy)
You Angie Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 73,731 0 - - Employee Stock Option (right to buy)
Song Kenneth Director, PRESIDENT AND CHIEF EXECUTIVE Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 480,000 0 - - Employee Stock Option (right to buy)
Heyman Richard A. Director Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 367,446 0 - 62.5 22,965,375 Common Stock
Song Kenneth Director, PRESIDENT AND CHIEF EXECUTIVE Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 1,622,968 0 - 62.5 101,435,500 Common Stock
Maha Katabi Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 18,235 0 - - Stock Option (right to buy)
J. Christy Oliger Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 114,579 0 - - Employee Stock Option (Right to Buy)
Kush Arvind CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 301,745 0 - - Employee Stock Option (Right to Buy)
Arvind Kush CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 164,000 0 - - Employee Stock Option (right to buy)
Tim Hauwermeiren Van Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 48,628 0 - - Stock Option (Right to Buy)
Kush Arvind CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 149,777 0 - - Employee Stock Option (right to buy)
Susan Moran CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 60,757 0 - - Employee Stock Option (right to buy)
Kenneth Song Director, PRESIDENT AND CHIEF EXECUTIVE Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Feb 2024 758,607 0 - - Employee Stock Option (right to buy)
Katabi Maha Director Sale or transfer of securities back to the company at price $ 62.50 per share. 26 Feb 2024 1,209,764 0 - 62.5 75,610,250 Common Stock
Susan Moran CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. 22 Jan 2024 30,875 322,647 - 3.2 100,035 Common Stock
Susan Moran CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2024 30,875 60,757 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters